Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders for the treatment of diseases lacking effective therapeutic approaches. The Company's research programs focus on novel treatment for cancer, inflammatory, and autoimmune diseases.
|HQ||San Diego, US||Map|
|Employees (est.) (Apr 2019)||4|
Cullgen total Funding
Cullgen latest funding size
Time since last funding
|a year ago|
|Highlight Capital, Sequoia Capital China, GNI Group|
When was Cullgen founded?
Cullgen was founded in 2018.
Who are Cullgen key executives?
Cullgen's key executives are Ying Luo, Thomas Eastling and Michael Plewe.
How many employees does Cullgen have?
Cullgen has 4 employees.
Who are Cullgen competitors?
Competitors of Cullgen include Alligator Bioscience, Ayala Pharmaceuticals and Actuate Therapeutics.
Where is Cullgen headquarters?
Cullgen headquarters is located at 12671 High Bluff Dr #130, San Diego.
Where are Cullgen offices?
Cullgen has offices in San Diego, Shanghai and Tokyo.
How many offices does Cullgen have?
Cullgen has 3 offices.
Receive alerts for 300+ data fields across thousands of companies